Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting

被引:0
|
作者
Fumi Gomi
Hideyuki Migita
Toshiaki Sakaguchi
Hiromi Okada
Tamotsu Sugawara
Yusuke Hikichi
机构
[1] Hyogo College of Medicine Hospital,
[2] Bayer Yakuhin,undefined
[3] CMIC Co,undefined
[4] Ltd,undefined
来源
关键词
Intravitreal aflibercept; NEI-VFQ-25; Wet age-related macular degeneration; J-PMS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:437 / 447
页数:10
相关论文
共 50 条
  • [31] Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration
    Zhu, Meidong
    Wijeyakumar, Wijeyanthy
    Syed, Adil R.
    Joachim, Nichole
    Hong, Thomas
    Broadhead, Geoffrey K.
    Li, Haitao
    Luo, Kehui
    Chang, Andrew
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (03) : 475 - 484
  • [32] Vision-related quality of life and clinical measures of visual function in age-related macular degeneration
    Pearce, Elizabeth
    Cassels, Nicola
    Sivaprasad, Sobha
    Margrain, Tom
    Blyth, Chris
    Wild, John
    Chong, Victor
    Acton, Jennifer
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [33] Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life
    Inoue, Maiko
    Arakawa, Akira
    Yamane, Shin
    Kadonosono, Kazuaki
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 1711 - 1716
  • [34] Quality of life in patients with wet age-related macular degeneration treated with photodynamic therapy
    Laouar, K.
    Dupeyron, G.
    Audemard, D.
    Arnaud, B.
    Arndt, C.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (03): : 233 - 238
  • [35] α-Lipoic Acid Treatment Improves Vision-Related Quality of Life in Patients with Dry Age-Related Macular Degeneration
    Tao, Yuan
    Jiang, Pengfei
    Wei, Yuhua
    Wang, Ping
    Suns, Xiaoling
    Wang, Hong
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 240 (03): : 209 - 214
  • [36] Real-world efficacy and safety of dividing aflibercept into three syringes in the treatment of wet age-related macular degeneration
    Hujanen, Pekko
    Tuulonen, Anja
    Uusitalo-Jarvinen, Hannele
    ACTA OPHTHALMOLOGICA, 2019, 97 (05) : E812 - E813
  • [37] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Rachel Hui Fen Lim
    Bhaskar Gupta
    Peter Simcock
    International Journal of Ophthalmology, 2017, (03) : 423 - 426
  • [38] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Lim, Rachel Hui Fen
    Gupta, Bhaskar
    Simcock, Peter
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (03) : 423 - 426
  • [39] Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
    Heier, Jeffrey S.
    Brown, David M.
    Chong, Victor
    Korobelnik, Jean-Francois
    Kaiser, Peter K.
    Quan Dong Nguyen
    Kirchhof, Bernd
    Ho, Allen
    Ogura, Yuichiro
    Yancopoulos, George D.
    Stahl, Neil
    Vitti, Robert
    Berliner, Alyson J.
    Soo, Yuhwen
    Anderesi, Majid
    Groetzbach, Georg
    Sommerauer, Bernd
    Sandbrink, Rupert
    Simader, Christian
    Schmidt-Erfurth, Ursula
    OPHTHALMOLOGY, 2012, 119 (12) : 2537 - 2548
  • [40] Early initial clinical experience with intravitreal aflibercept for wet age-related macular degeneration
    Ferrone, Philip J.
    Anwar, Farihah
    Naysan, Jonathan
    Chaudhary, Khurram
    Fastenberg, David
    Graham, Kenneth
    Deramo, Vincent
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 : 17 - 21